MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 116 filers reported holding MAXCYTE INC in Q2 2023. The put-call ratio across all filers is 4.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,107 | -25.2% | 30,483 | +10.0% | 0.00% | – |
| Q2 2023 | $127,157 | -1.0% | 27,703 | +6.8% | 0.00% | – |
| Q1 2023 | $128,428 | +4.1% | 25,945 | +14.9% | 0.00% | – |
| Q4 2022 | $123,320 | +28.5% | 22,586 | +64.2% | 0.00% | – |
| Q1 2022 | $96,000 | -27.3% | 13,753 | +6.0% | 0.00% | – |
| Q4 2021 | $132,000 | – | 12,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 372,000 | $4,542,000 | 4.32% |
| Casdin Capital, LLC | 13,971,334 | $170,590,000 | 4.25% |
| Montanaro Asset Management Ltd | 2,549,000 | $30,996,000 | 3.74% |
| HARBERT FUND ADVISORS, INC. | 724,856 | $8,850,000 | 3.14% |
| Nine Ten Capital Management LLC | 1,900,968 | $23,211,000 | 2.48% |
| RIVER GLOBAL INVESTORS LLP | 2,305,500 | $27,978,000 | 2.17% |
| Vitruvian Partners LLP | 3,330,000 | $40,659,000 | 1.70% |
| Nicholas Investment Partners, LP | 980,122 | $11,967,000 | 0.87% |
| First Light Asset Management, LLC | 994,670 | $12,145,000 | 0.80% |
| AREX Capital Management, LP | 126,968 | $1,550,000 | 0.72% |